Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study

Fig. 1

Selection of study and PS-matched cohorts of new users of SGLT2i and DPP4i in South Korea. †Acute respiratory disease includes acute pulmonary edema, acute respiratory syndrome, pneumonia, and respiratory failure. DPP4i, dipeptidyl peptidase-4 inhibitor; ESRD, end-stage renal disease; HIRA, Health Insurance Review and Assessment Service; PS, propensity score; SGLT2i, sodium-glucose cotransporter 2 inhibitors

Back to article page